Stay updated on Tagraxofusp in Secondary AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page history shows a new UI revision entry (Revision: v3.3.2) and removal of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe government funding and operating status notice has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check42 days agoChange DetectedA new version entry has been added to the Record History with a newer submission date, updating the study status in the history table. This reflects the ongoing updates to the trial record on ClinicalTrials.gov.SummaryDifference0.1%

- Check70 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference12%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check85 days agoChange DetectedUpdated date stamps and added study status contacts/locations (new 2025-09-19 and 2025-09-16), removing an older entry from 2025-06-22; this signals refreshed but not drastically altered core content.SummaryDifference1%

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.